Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0U7SU
|
|||
| Former ID |
DNCL001572
|
|||
| Drug Name |
Interferon-alpha lozenge
|
|||
| Synonyms |
Veldona (TN)
Click to Show/Hide
|
|||
| Indication | Behcet disease [ICD-11: 4A62] | Phase 2 | [1] | |
| Chronic obstructive pulmonary disease [ICD-11: CA22; ICD-10: J44, J44.9] | Phase 2 | [1] | ||
| Fibromyalgia [ICD-11: MG30.01; ICD-10: M79.7] | Phase 2 | [1] | ||
| Company |
Amarillo Biosciences
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Clinical pipeline report, company report or official report of Amarillo Biosciences. | |||
| REF 2 | Interferon-alpha. Amarillo Biosciences. Curr Opin Investig Drugs. 2002 May;3(5):693-7. | |||
| REF 3 | Successful application of highly purified natural interferon alpha (multiferon) in a chronic hepatitis C patient resistant to preceding treatment approaches. Hepatogastroenterology. 2004 Sep-Oct;51(59):1476-9. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.